Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Kerry J. Savage, MDMSc, Joseph M. Connors, MD, Diego R Villa, MDMPH, Greg Hapgood, MD, Alina S Gerrie, MD, Tamara N Shenkier, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne, Francois Benard, MD, James Morris, MD, Tom Pickles, MD, Christina Parsons, MD, Don Wilson, MD, Laurie H. Sehn

Blood (2015) 126 (23): 579.

https://doi.org/10.1182/blood.V126.23.579.579

Published: 2015

Journal Articles

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

Nancy D. Doolittle, Lauren E. Abrey, Tamara N. Shenkier, Siegal Tali, Jacoline E.C. Bromberg, Edward A. Neuwelt, Carole Soussain, Kristoph Jahnke, Patrick Johnston, Gerald Illerhaus, David Schiff, Tracy Batchelor, Silvia Montoto, Dale F. Kraemer, Emanuele Zucca

Blood (2008) 111 (3): 1085–1093.

https://doi.org/10.1182/blood-2007-07-101402

Published: 2008

Includes: Supplemental data

Journal Articles

Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.

Abdulwahab J. Al-Tourah, MB BCh, FRCPC, Kerry J. Savage, MD, MPH, FRCPC, Karamjit K. Gill, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Laurie H. Sehn, MD, FRCPC, Tamara N. Shenkier, ND, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2007) 110 (11): 790.

https://doi.org/10.1182/blood.V110.11.790.790

Published: 2007

Journal Articles

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Agnieszka Korfel, MD, Kristoph Jahnke, MD, Brian P. O’Neill, MD, Jean-Yves Blay, MD, Lauren Abrey, MD, Peter Martus, Philip M.P. Poortmans, MD, Tamara N. Shenkier, MD, Tracy T. Batchelor, MD, Edward A. Neuwelt, MD, Jeffrey J. Raizer, MD, Hendrik Pels, MD, Ulrich Herrlinger, MD, Eckhard Thiel, MD

Blood (2005) 106 (11): 3343.

https://doi.org/10.1182/blood.V106.11.3343.3343

Published: 2005

Journal Articles

Transformed Lymphoma: Incidence and Long-Term Outcome.

Abdulwahab J. Al-Tourah, MB, BCh, FRCPC, Mukesh Chhanabhai, MD, FRCPC, Paul J. Hoskins, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Kerry J. Savage, MD, FRCPC, Laruie H. Sehn, MD, FRCPC, Tamara N. Shenkier, MD, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2004) 104 (11): 3253.

https://doi.org/10.1182/blood.V104.11.3253.3253

Published: 2004

NARROW

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Transformed Lymphoma: Incidence and Long-Term Outcome.

Email alerts

ASH Publications

American Society of Hematology

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Transformed Lymphoma: Incidence and Long-Term Outcome.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only